The head of the U.S. Food and Drug Administration, Scott Gottlieb said this week the agency is “doing all it can” to support the immediate needs of Puerto Ricans after Hurricane María’s destruction, as well ...
The U.S. Food and Drug Administration recently gave the go-ahead to two new drugs, Xeljanz and Quillivant XR, to treat rheumatoid arthritis and Attention Deficit Hyperactivity Disorder, respectively, the manufacturing companies announced in separate statements.